1. An association has been reported between QT interval abnormalities and cardiovascular autonomic neuropathy in diabetic patients. The QT interval abnormalities reflect local inhomogeneities of ventricular recovery time and may be related to an imbalance in cardiac sympathetic innervation. Sympathetic innervation of the heart can be visualized and quantified by single-photon emission-computed tomography with rn- [ 1231] iodobenzylguanidine. In this study we evaluated cardiac sympathetic integrity by rn- [1231] iodobenzylguanidine imaging and the relationship between both QT interval prolongation and QT dispersion from standard 12-lead ECG variables and rn- [ 1231] iodobenzylguanidine uptake in insulin-dependent diabetic patients. 2. Three patient groups were studied, comprising six healthy control subjects, nine diabetic patients without cardiovascular autonomic neuropathy (CAN-) and 12 diabetic patients with cardiovascular neuropathy (CAN+). Resting 12-lead ECG was recorded for measurement of maximal QT interval and QT dispersion. The QT interval was heart rate corrected using Bazett's formula (QTc) and the Karjalainen approach (QTK). Quantitative measurement (in counts/min per g) and visual defect pattern of rn- [1231] iodobenzylguanidine uptake were performed using rn- [1231] iodobenzylguanidine single-photo emission-computed tomography. 3. Global myocardial rn-[1231] iodobenzylguanidine uptake was significantly reduced in both diabetic patient groups compared with control subjects. The visual defect score of rn- [ 1231] iodobenzylguanidine uptake was significantly higher in CAN+ diabetic patients than in control subjects and in CANpatients. This score was not significantly different between control subjects and CAN-patients. QT, interval and QT dispersion were significantly increased in CAN+ diabetic patients as compared with control subjects (QT,: 432f15 ms versus 404 f 19 ms, P < 0.05; QT dispersion: 42 f 10 versus 28 f 8 ms, P < 0.05). QT dispersion was also significantly longer in CAN-diabetic patients than in control subjects (41f9 ms versus 2 8 f 8 ms, P<O.O5). QT, interval was significantly related to global myocardial rn- [ 1231] iodobenzylguanidine uptake and defect score in diabetic patients (r = -0.648, P<O.Ol, and r = 0.527, P<O.O5, respectively). There was no correlation between QT dispersion and both rn- [lul] iodobenzylguanidine uptake measures. 4. In conclusion, these findings suggest that rn- [ 1231] iodobenzylguanidine imaging is a valuable tool for the detection of early alterations in myocardial sympathetic innervation in long-term diabetic patients without cardiovascular autonomic neuropathy. Insulin-dependent diabetic patients with cardiovascular autonomic neuropathy have a delayed cardiac repolarization and increased variability of ventricular refractoriness. The cardiac sympathetic nervous system seems to be one of the determinants of QT interval lengthening, but does not appear to be involved in dispersion of ventricular recovery time. It is assumed that QT dispersion
INTRODUCTION
Cardiovascular autonomic neuropathy (CAN) is a well-recognized complication in patients with diabetes mellitus and is associated with an increased risk of mortality [l] . The diagnosis of CAN is based on indirect non-invasive autonomic function tests, including standard indices of heart rate variation and blood pressure responses to physiological man-oeuvres [2] . A direct detection of cardiac sympathetic nerve damage is possible with rn-[1231]iodobenzylguanidine (lz3I-MIBG), a structural analogue of noradrenaline, which shares the same uptake-1 mechanism in postganglionic presynaptic sympathetic nerve terminals [3] . It has been demonstrated that cardiac sympathetic nerve damage by stellate ganglionectomy [4] , heart transplantation [5, 61, transmural myocardial infarction [7] or symptomatic autonomic neuropathy in patients with long-term diabetes mellitus [3, [8] [9] [10] [11] [12] and Shy-Drager syndrome [13] produces a marked loss of cardiac 1231-MIBG uptake. Alterations in myocardial lz3I-MIBG uptake have also been detected in diabetic patients with subclinical autonomic abnormalities [14] . While some studies reported a correlation between cardiac sympathetic denervation assessed by single-photon-(SPECT) [lo, 11, 151 or positronemission [ 161 tomography and conventional measures of autonomic nervous dysfunction in diabetic patients, others could not detect such a relationship [9, 121. The principle finding of cardiac scintigraphic studies in long-term diabetic patients is a reduction or loss of myocardial 1231-MIBG uptake with predominant involvement of the posterior and inferior wall of the left ventricle [14] . The same pattern of cardiac sympathetic denervation can be observed in experimental studies in dogs after left stellate ganglionectomy [4] . Under the assumption that these results in animal experiments are also valid for humans, it appears that there is an increased susceptibility of the left arm of cardiac sympathetic nerves to neuropathic damage. A similar pattern of nonhomogeneous cardiac 1231-MIBG uptake was found in patients with the long QT syndrome [17] . Despite the differences in the underlying pathogenetic mechanisms responsible for reduced myocardial 1231-MIBG uptake in diabetes mellitus and the long QT syndrome, prolonged QT intervals and increased QT dispersion are found in both . These QT interval abnormalities represent the variation in repolarization in different myocardial regions and may reflect inhomogeneities in left-sided sympathetic innervation [20] . However, it is unclear whether there is a relationship between cardiac sympathetic dysinnervation and QT interval abnormalities in diabetic patients. An inverse correlation between 1231-MIBG uptake and QT interval prolongation has been found in non-insulin-dependent diabetic patients [15] , while another study could not confirm this correlation [ll] . Also, in a study using QT dispersion, a different measure of variability in ventricular refractoriness, no correlation with 1231-MIBG uptake in diabetic patients could be demonstrated [21] .
By contrast, in two other studies no correlation between 1231-MIBG uptake and QT interval prolongation and QT dispersion (a simple measure of dispersion of ventricular refractoriness) could be demonstrated in diabetic patients Ell, 211.
The purpose of this study was (i) to evaluate cardiac sympathetic integrity in patients with longterm diabetes mellitus by means of '231-MIBG SPECT, and (ii) to examine the relationship between electrocardiographic indices of prolongation as well as dispersion of cardiac repolarization and myocardial 1231-MIBG uptake.
METHODS

Subjects
Three groups of subjects were selected for the study: (1) six healthy control subjects; (2) 12 Type 1 diabetic patients without evidence of CAN (CAN -) and (3) nine Type 1 diabetic patients with evidence of CAN (CAN+). The clinical features of the six control subjects and the 21 diabetic patients are shown in Table 1 . Age and anthropometric characteristics were comparable in each group studied. There were no significant differences regarding the remaining parameters listed between the patients allocated to the CAN+ group and those who were assigned to the CAN-group.
Criteria for entry into the study included history of hyperglycaemia with or without ketonuria, requirement of insulin at the time of diagnosis of diabetes and absence of alcohol abuse, drugs known to influence somatic or autonomic nerve function, neuropathy other than of diabetic origin, and known or suspected coronary artery disease or previous myocardial infarction. Diabetic polyneuropathy was diagnosed on the basis of neurological history, examination and nerve conduction studies.
The control subjects included in this study manifested no signs of an acute organic or systemic disease, as confirmed by medical history, clinical examination and 12-lead ECG. None of the healthy subjects was on any medication.
Written informed consent was obtained from all subjects, and the study protocol was approved by the Ethics Committee of the Heinrich-Heine-University of Diisseldorf.
'231-MIBG SPECT
All patients and normal subjects received 900 mg of sodium perchloride orally at 48 h, 24 h and 1 h before tracer injection to block possible uptake of free radioactive iodide by the thyroid. The specific activity of '231-MIBG (CYGNE BV, Eindhoven, The Netherlands) was between 260 and 480 MBq/mmol, the radionuclide purity was >99.95% and the radiochemical purity was at least 98%. A fine-gauge intravenous canula was placed in an antecubital vein of the left arm and the patient remained in a supine position for 30 min to take blood samples for the measurement of noradrenaline and adrenaline. Thereafter, 370 MBq of 1231-MIBG was injected via the intraveneous canula. The amount of tracer radioactivity injected was determined exactly by measuring the radioactivity in the syringe before and after tracer injection. The first SPECT study was performed from 15 to 45 min, after injection and a second SPECT study was performed from 120 to 150 min after injection. For the assessment of late '231-MIBG uptake the 2 h scan was chosen, as it has been shown to be representative of specific '231-MIBG retention. Four hour scans, which were used by some authors [12, 141 , have shown no advantage over 2 h scans in detecting late binding [22] . Also, from experimental data no significant difference between 2 h and 4 h scans should be expected, because washout of unspecifically bound 1231-MIBG radioactivity occurs within the first minutes after injection. The evaluation of washout rates from early to late scans and heart to mediastinum ratios from planar views were also considered but did not show any group differences or relationship to electrophysiological parameters (data not shown). The studies were performed using a triple-headed SPECT system (Trionix Triad, Twinsburg, OH, U.S.A.) equipped with high-resolution parallel hole collimators. The SPECT data were reconstructed by filtered back projection in a 128 x 64 matrix with a pixel size of 3.56 mm using a butterworth filter (0.35 highcut, 3.0 roll-off). Data were corrected for attenuation [23] (1978/first order p = 0.1) using a contour-finding procedure. No scatter correction was applied. Vertical and transversal long axis sections of the left ventricle were generated. Four slices in the centre of the vertical long axis and in the centre of the transversal long axis were added up, yielding a slice thickness of 1.42 cm. The slices were evaluated by cubical regions of interest (ROIs) of 4 x 4 x 4 (1.42 x 1.42 x 1.42 cm) pixels so that the ROI covered a cubical volume of 2.9ml. These ROIs were placed in the following positions ( Fig. 1 ): (i) in the vertical long axis section: on the basal part of the anterior wall, apical part of the anterior wall, apex, apical part of the posterior wall, basal part of the posterior wall; (ii) in the transversal long axis section: on the basal part of the septum, apical part of the septum, apex again, apical part of the lateral wall, and basal part of the lateral wall. For the apical ROI a mean value from the region in the vertical and transversal longitudinal sections was calculated. Thus, for each heart evaluation the data from nine regions of interest were available. Myocardial 123-MIBG uptake was quantified in countdmin per ml of tissue normalized to injected dose and body weight. A mean value of the ratios of cardiac ROIs was calculated to estimate global cardiac uptake. This evaluation was performed for the early '231-MIBG scans as well as for the late 1231-MIBG scans. Additionally, a semi-quantitative approach similar to that of Kim et al. [12] was used. For this purpose, the vertical and tranversal long axis sections of the late SPECT scans were visually evaluated by two independent observers, who did not know the clinical history of the study group subjects. 1231-MIBG uptake in the different regions was scored according to the following criteria considering relative uptake values from the ROI analysis: grade 0 (normal, homogeneous uptake); grade 1 (diminished uptake, >50% of left ventricular maximum); grade 2 (diminished uptake, ~5 0 % of left ventricular maximum); grade 3 (nonvisualized myocardium). The score obtained in each region was then added up to obtain the global 1231-MIBG defect score. In all subjects with cardiac lz3I-MIBG uptake defects, a myocardial perfusion scintigraphy after maximal bicycle exercise was performed with 99mTc Sesta-MIBI SPECT to exclude coronary artery disease [24] . This was done in 14 out of 21 diabetic patients and all of these patients were able to perform the exercise challenge test.
Electrocardiographic measurement
Three different indirect measures of repolarization of the ventricular myocardium were used: (1) heart rate adjusted QT interval according to the Bazett formula QTc = QT/RR1/2 [25] ; (2) heart rate adjusted QT interval using a nomogram developed by Karjalainen et al. [26] based on the calculation of three linear regression equations for three ranges of interbeat intervals (< 600 ms, 600-1000 ms and >lOOOms, QTK); and (3) QT dispersion [27] . Measurements of these indexes were obtained from a 12-lead resting ECG at a paper speed of 50 mm/s.
All subjects were in sinus rhythm and had no conduction abnormalities of the QRS complex. QT interval was measured from the earliest onset of the QRS complex to the end of the T wave. The T wave end was defined as the return of the T wave downward slope to T-P baseline. When U waves were present the QT interval was measured from the onset of the QRS complex to the nadir of the curve between the T and U waves. QT and the preceding RR interval were measured for three consecutive cycles and then averaged. At least nine of 12 analysable ECG leads were required for inclusion in the data analysis and calculation of the mean QT and QTc interval. Q T dispersion was defined as the difference between the maximal and minimal QT interval in any of at least nine ECG channels, respectively. Measurements were obtained manually by one observer, who was unaware of the subject's clinical status.
Cardiovascular autonomic function tests
Tests based on heart rate variability were performed with a ProSciCard system (MediSyst, Linden Germany) as described elsewhere [28] . Briefly, they included the coefficient of variation of heart rate, and low and high-frequency components of heart rate spectral analysis in the supine position, mean circular resultant of heart rate during deep breathing Valsalva ratio and the maximum/minimum 30:15 heart rate ratio to standing up. The blood pressure response to standing up was performed with a Dinamap 1846 SX monitoring system (Criticon, Norderstedt, Germany) as described previously [28] . Results of the autonomic cardiovascular function tests in the diabetic patients were compared with normal ranges using a data set of autonomic function tests performed in 120 non-diabetic subjects with an age range of 15-67 years. The agedependent lower limits of normal were defined at the 2.3 percentile as reported previously . [28] . According to the test results, the diabetic patients were subdivided into two groups, i.e. patients with CAN (CAN+, three or more abnormal test results of the seven parameters performed), and those without CAN (CAN-, less than three abnormal test results of the seven parameters performed) 1281.
Analytical methods and retinopathy assessment
HbAlc was determined by HPLC with a Diamat analysing system (Bio-Rad, Munich, Germany). The normal range is <6.3%. Capillary blood glucose was measured by the hexokinase method of an ACP 5040 autoanalyser (Eppendorf, Hamburg, Germany). Determination of urinary albumin excre- tion rate was determined in samples collected over 24 h using the immuno-nephelometric technique (ARRAY protein system, Beckman, Fullerton, CA, U.S.A.). Adrenaline and noradrenaline were analysed by reversed-phase HPLC with electrochemical determination [29] .
Retinopathy was assessed by colour retinophotographs using a CR3-45 NM non-mydriatic retinocamera (Canon, Tokyo, Japan).
Statistical analysis
Data are expressed as mean+SD. Differences in group means were compared using one-way analysis of variance followed by Dunn's test for multiple comparisons. Associations between variables were studied by linear regression using a least-squares technique. A probability level of Px0.05 was considered statistically significant. Table 2 shows the results of standard autonomic function tests and electrocardiographic measurements. Diabetic patients with three or more abnormal autonomic tests (CAN+) had a significantly lower coefficient of heart rate variation, lowfrequ ncy and high-frequency heart rate power, minimum 30:15 ratio and a significantly greater fall in postural systolic blood pressure than did those with less than three abnormal autonomic tests (CAN-) (P<O.O5). Mean RR interval at rest tended to be shorter in diabetic patients than in control subjects. A significant QTc prolongation was found in CAN+ patients as compared with control subjects. QT dispersion was significantly higher in mean P circular resultant, Valsalva ratio, maximum/ both diabetic subgroups than in controls. There was no significant difference in QTK interval between the three groups studied.
RESULTS
Autonomic function tests and ECG variables
'231-MIBG SPECT
The results of the global and regional myocardial 1231-MIBG uptake (counts/min per g) are given in Table 3 . Global myocardial 1231-MIBG uptake was significantly reduced in both diabetic groups compared with control subjects in the early as well as the late 1231-MIBG scans. Fig. 1 shows an example of myocardial 1231-MIBG SPECT in a patient with autonomic dysfunction. The 1231-MIBG uptake in this patient is markedly reduced in the posterior and inferior walls and the apex of the left ventricle. This represents the typical 1231-MIBG defect pattern in patients with CAN. In none of the subjects studied did the anterior wall show a 1231-MIBG defect without involvement of the posterior wall.
In a second, semi-quantitative analysis of myocardial 1231-MIBG defects it was found that diabetic patients with CAN had a significant higher 1231-MIBG defect score than those without CAN (10.78k7.14 versus 3.42k3.15, P<0.05) and controls (10.7847.14 versus 0.83k1.17, P<0.05). The 1231-MIBG score was not significantly different between patients without CAN and control subjects.
Relationship between autonomic function tests, ECG variables and scintigraphic findings in diabetic patients
The extent and severity of late global myocardial lZ3I-MIBG defects (expressed as reduced lZI-MIBG uptake or increased 1231-MIBG score) was significantly related to the heart rate corrected QT interval (QTc and QTK) in diabetic patients ( Table 4) . Fig. 2 shows the negative correlation between late global myocardial 1231-MIBG uptake and the heart rate corrected QT interval ( -0.648, P < 0.01, n = 19). No correlation was observed between the 1231-MIBG defects and QT dispersion. Futhermore, the 1231-MIBG uptake showed a positive correlation with the systolic blood pressure response to standing, whereas the 1231-MIBG score showed an inverse correlation with this test (Table 4) .
DISCUSSION
The principle findings of this study are (i) a marked diminished myocardial 1231-MIBG uptake in long-term insulin-dependent patients with and without CAN, (ii) a significant lengthening of QTc interval and increase of QT dispersion in diabetic patients, particularly in those with CAN, and (iii) a relationship between QTc interval prolongation and myocardial 1231-MIBG uptake in diabetic patients. No correlation was observed between QT dispersion and 1231-MIBG uptake. These findings suggest that 586f2 I7* '231-MIBG imaging is a valuable tool for the detection of early alterations in myocardial sympathetic innervation in long-term diabetic patients without CAN. Furthermore, insulin-dependent diabetic patients with CAN have a delayed cardiac repolarization and increased variability of ventricular refractoriness. The cardiac sympathetic nervous system seems to be one of the determinants of QT interval lengthening, but does not appear to be involved in dispersion of ventricular recovery time.
It is assumed that QT dispersion is based on more complex electrophysiological mechanisms which remain to be elucidated. Myocardial sympathetic innervation was assessed using lZ3I-MIBG imaging [30] . MIBG shares with noradrenaline the same energy-requiring Uptake-1 mechanism into postsynaptic preganglionic sympathetic nerve terminals [31, 321 and is also taken up by a low-affinity mechanism into non-neuronal tissue [3, 4, 331. Because non-neuronal 1231-MIBG clears from the human heart as early as 3 min after injection [34] , later cardiac Iz31-MIBG activity has been successfully applied to study cardiac sympathetic innervation in physiological and pathophysiological circumstances. Data acquisition was performed after this early dynamic phase at 15 min and 120 min after injection. We obtained comparable group differences of myocardial lZ31-MIBG uptake among control subjects and diabetic patients in both early and late images (Table 3) . This supports the view that no significant non-neuronal 1231-MIBG uptake occurs at these time-points and early Iz3I-MIBG scans may be sufficient for detection of regional myocardial denervation [35] . Nevertheless, the late 1231-MIBG scans may demonstrate more reliably the stable intravesicular '231-MIBG uptake in cardiac sympathetic neurons [34] and were used, therefore, to determine the '231-MIBG defect score and to assess its relationship to autonomic function tests and QT intervals.
In control subjects we found an inhomogeneous '231-MIBG distribution with an essentially base-to- apex orientation of 1231-MIBG uptake (Table 3) . This is in line with previous reports [3, 10, 361 and has been related to the noradrenaline content in mammalian myocardium [7, 371 . Recently, Tsuchimochi et al.
[38] demonstrated a reduction in 1231-MIBG uptake in the inferior wall with increasing age in normal subjects, particularly men. Our control group consisted mostly of male subjects with an age comparable with that of the older subject group studied by Tsuchimochi et al. [38] . Therefore, heterogeneity of '231-MIBG uptake in our control subjects seems to reflect the aging process of myocardial sympathetic nerve tissue; the mechanism leading to this heterogeneous pattern remains to be explained. Our study also demonstrates a profound loss of myocardial 1231-MIBG uptake in patients with longterm insulin-dependent diabetes mellitus even with normal results in autonomic function tests (Table 3) . This finding confirms previous data [8, 9, 11, 141 and suggests that '"I-MIBG imaging is a more sensitive tool than the battery of autonomic function tests used in this study to assess abnormalities in cardiac autonomic innervation in diabetic patients. Interestingly, a significant relationship was obtained between myocardial lZ3I-MIBG uptake and defect and systolic blood pressure response to orthostatic stress, a test which assesses the cardiovascular sympathetic innervation indirectly (Table 4) . This illustrates that the sympathetic nervous system is generally involved in the diabetic disease process. Because the other autonomic function tests used in this study reflect the complex, mainly parasympathetic, control of heart rate and heart rate variability, it is not surprising that no correlation between the outcome of these autonomic function tests and lz3I-MIBG scintigraphy was found (Table 4 ). The development of new radioligands suitable for assessing parasympathetic nerve terminals may render possible a more complete exploration of cardiac autonomic innervation.
The profound loss of 1231-MIBG uptake in longterm diabetic patients is most probably due to structural lesions of the postganglionic presynaptic sympathetic nerve endings [5, 8, 12, 391 . This interpretation is based on experimental studies showing that cardiac sympathetic nerve damage by stellate ganglionectomy [4] , epicardial phenol application [4, 40, 411 or administration of 6-hydroxydopamine [3, 351 produces a marked decrease in myocardial 1231-MIBG uptake [4, 35, 411 . Sympathetic denervation in these studies was demonstrated by biochemical or electrophysiological techniques [41] . Further supportive evidence is provided by Calkins et al. [42] , who verified a correlation between sympathetic innervation defects detected by positron-emission tomography using ["C] hydroxyephedrine and sympathetic denervation detected by refractory period responses in humans.
There are other possible reasons for Iz3I-MIBG uptake defects. First, patients with coronary artery disease may develop regional cardiac sympathetic denervation [43] . In our study, however, myocardial perfusion abnormalities in diabetic patients with a 1231-MIBG uptake defect were excluded by 9 9 m T~ Sesta-MIBI scintigraphy. Secondly, noradrenaline competitively blocks 1231-MIBG uptake [44, 451. Increased levels of circulating noradrenaline in patients with pheochromocytomas suppress cardiac uptake of lZ3I-MIBG [31] . However, we observed no increase in venous plasma noradrenaline concentration in the diabetic patients studied (Table 1) . This confirms a previous report [S] , and suggests that competitive inhibition between noradrenaline and 1231-MIBG is hardly a plausible explanation for myocardial lz3I-MIBG uptake defects present in longterm diabetic patients. Even if it is assumed that plasma noradrenaline values cannot provide direct information about the cardiac sympathetic nerve function, one should consider that post-mortem analysis of long-term diabetic patients with autonomic neuropathy revealed markedly reduced noradrenaline concentration in the heart [39] . Therefore, it is also unlikely that sympathetic hyperactivity at the synaptic site of the heart is responsible for '231-MIBG uptake defects in long-term diabetic patients. This is supported by our finding that early and late scintigraphic images showed the same Iz3I-MIBG distribution pattern (Table 3 ) and insignificant washout rates (data not shown). Furthermore, it is reasonable to assume that competitive inhibition by noradrenaline would affect the lZ3I-MIBG uptake of the entire myocardium and would not produce a regional defect pattern.
The maximal heart rate adjusted QT interval calculated from Bazett's formula was observed to be prolonged in diabetic patients with autonomic dysfunction, supporting earlier results [18, 46, 471 . Heart rate adjusted QT interval, according to the approach of Karjalainen et al. [26] , tended to be longer in CAN+ diabetic patients than in control subjects. The QT interval dispersion was significantly increased in diabetic patients with and without autonomic dysfunction when compared with control subjects, confirming previous data [19, 211. In the present study, the QT interval abnormalities (QTc and QTK), but not QT dispersion, were correlated with the 1231-MIBG uptake defect in diabetic patients, suggesting that prolongation of repolarizatin rather than inhomogeneity of repolarization is associated with the degree of left ventricular sympathetic denervation (Table 4) . Although both QT interval prolongation and increased QT dispersion are present in diabetic patients with autonomic dysfunction, these phenomena seem to be mediated by different electrophysiological mechanisms. Recently, the relationship between QT interval and lZ3I-MIBG uptake has been discussed controversially [ll, 151. Regarding the lack of correlation between QT dispersion and '231-MIBG uptake, we confirm the finding of Wei et al. [21] .
QT interval prolongation has been related to alterations of the autonomic nervous system activity and to an increased occurrence of complex ventricular tachyarrhythmia and sudden death [48] . By analogy with the long QT syndrome it has been speculated that increased QT interval length in diabetic patients with autonomic dysfunction might be associated with an increased risk of sudden death [l] . The long QT syndrome is characterized by recurrent episodes of syncopes or cardiac arrest due to Torsade de pointes and has been attributed to possibly increased left-sided versus decreased rightsided sympathetic drive to the heart [48] . Interestingly, similar regional abnormalities in myocardial 1231-MIBG uptake was demonstrated in patients with the long QT syndrome [17] and in the present series of patients with diabetes mellitus despite the pathogenetic differences. It was found that diabetic patients with autonomic dysfunction who died within a 3-year follow-up showed prolonged QT intervals when compared with those who survived [l] . However, another study [49] could not confirm these observations and the question of the predictive value of the prolonged QT interval in view of the increased mortality in diabetic patients with autonomic dysfunction remains open. In fact, fatal ventricular arrhythmias have been reported only anecdotally in diabetic patients with reduced 1231-MIBG uptake or increased QT dispersion [50] .
In conclusion, this study demonstrates QT interval abnormalities and myocardial 1231-MIBG uptake defects in insulin-dependent patients indicating a diabetes-related disturbance of ventricular repolarization and cardiac sympathetic dysinnervation, respectively. Myocardial 1231-MIBG imaging is a useful marker of cardiac sympathetic nerve integrity in long-term diabetic patients. The prognostic significance of scintigraphic data and whether they reflect irreversible lesions or potentially reversible dysfunction of cardiac sympathetic nerve endings in these patients should be further studied.
